Literature DB >> 29095376

Circulating Lipids and Acute Pain Sensitization: An Exploratory Analysis.

Angela Starkweather1, Thomas Julian, Divya Ramesh, Amy Heineman, Jamie Sturgill, Susan G Dorsey, Debra E Lyon, Dayanjan Shanaka Wijesinghe.   

Abstract

BACKGROUND: In individuals with low back pain, higher lipid levels have been documented and were associated with increased risk for chronic low back pain.
OBJECTIVES: The purpose of this research was to identify plasma lipids that discriminate participants with acute low back pain with or without pain sensitization as measured by quantitative sensory testing.
METHODS: This exploratory study was conducted as part of a larger parent randomized controlled trial. A cluster analysis of 30 participants with acute low back pain revealed two clusters: one with signs of peripheral and central sensitivity to mechanical and thermal stimuli and the other with an absence of peripheral and central sensitivity. Lipid levels were extracted from plasma and measured using mass spectroscopy.
RESULTS: Triacylglycerol 50:2 was significantly higher in participants with peripheral and central sensitization compared to the nonsensitized cluster. The nonsensitized cluster had significantly higher levels of phosphoglyceride 34:2, plasmenyl phosphocholine 38:1, and phosphatidic acid 28:1 compared to participants with peripheral and central sensitization. Linear discriminant function analysis was conducted using the four statistically significant lipids to test their predictive power to classify those in the sensitization and no-sensitization clusters; the four lipids accurately predicted cluster classification 58% of the time (R = .58, -2 log likelihood = 14.59). DISCUSSION: The results of this exploratory study suggest a unique lipidomic signature in plasma of patients with acute low back pain based on the presence or absence of pain sensitization. Future work to replicate these preliminary findings is underway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29095376      PMCID: PMC5679413          DOI: 10.1097/NNR.0000000000000248

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  23 in total

1.  Body mass index and distribution of body fat can influence sensory detection and pain sensitivity.

Authors:  O A Tashani; R Astita; D Sharp; M I Johnson
Journal:  Eur J Pain       Date:  2017-03-06       Impact factor: 3.931

2.  Serum lipids and low back pain: an association? A follow-up study of a working population sample.

Authors:  Päivi Leino-Arjas; Leena Kaila-Kangas; Svetlana Solovieva; Hilkka Riihimäki; Juhani Kirjonen; Antti Reunanen
Journal:  Spine (Phila Pa 1976)       Date:  2006-04-20       Impact factor: 3.468

3.  A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain.

Authors:  M Roland; R Morris
Journal:  Spine (Phila Pa 1976)       Date:  1983-03       Impact factor: 3.468

4.  Methods to measure peripheral and central sensitization using quantitative sensory testing: A focus on individuals with low back pain.

Authors:  Angela R Starkweather; Amy Heineman; Shannon Storey; Gil Rubia; Debra E Lyon; Joel Greenspan; Susan G Dorsey
Journal:  Appl Nurs Res       Date:  2015-04-08       Impact factor: 2.257

5.  The impact of body mass index on the prevalence of low back pain: the HUNT study.

Authors:  Ingrid Heuch; Knut Hagen; Ivar Heuch; Øystein Nygaard; John-Anker Zwart
Journal:  Spine (Phila Pa 1976)       Date:  2010-04-01       Impact factor: 3.468

6.  Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry.

Authors:  Alfred H Merrill; M Cameron Sullards; Jeremy C Allegood; Samuel Kelly; Elaine Wang
Journal:  Methods       Date:  2005-06       Impact factor: 3.608

7.  Evaluation of intramyocellular and extramyocellular lipids in the paraspinal muscle in patients with chronic low back pain using MR spectroscopy: preliminary results.

Authors:  Hiroyuki Takashima; Tsuneo Takebayashi; Izaya Ogon; Mitsunori Yoshimoto; Yoshinori Terashima; Rui Imamura; Toshihiko Yamashita
Journal:  Br J Radiol       Date:  2016-06-02       Impact factor: 3.039

8.  The long-lasting sensitization of primary afferent nociceptors induced by inflammation involves prostanoid and dopaminergic systems in mice.

Authors:  Cristiane Flora Villarreal; Mani Indiana Funez; Fernando de Queiroz Cunha; Carlos Amílcar Parada; Sérgio Henrique Ferreira
Journal:  Pharmacol Biochem Behav       Date:  2012-11-20       Impact factor: 3.533

9.  Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.

Authors:  Kirsi H Pietiläinen; Marko Sysi-Aho; Aila Rissanen; Tuulikki Seppänen-Laakso; Hannele Yki-Järvinen; Jaakko Kaprio; Matej Oresic
Journal:  PLoS One       Date:  2007-02-14       Impact factor: 3.240

10.  Do abnormal serum lipid levels increase the risk of chronic low back pain? The Nord-Trøndelag Health Study.

Authors:  Ingrid Heuch; Ivar Heuch; Knut Hagen; John-Anker Zwart
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

View more
  3 in total

1.  Metabolomics Research Conducted by Nurse Scientists: A Systematic Scoping Review.

Authors:  Laura P Kimble; Sharon Leslie; Nicole Carlson
Journal:  Biol Res Nurs       Date:  2020-07-10       Impact factor: 2.522

2.  Somatosensory Profiles Differentiate Pain and Psychophysiological Symptoms Among Young Adults With Irritable Bowel Syndrome: A Cluster Analysis.

Authors:  Jie Chen; Yiming Zhang; Zahra A Barandouzi; Wanli Xu; Bin Feng; Ki Chon; Melissa Santos; Angela Starkweather; Xiaomei Cong
Journal:  Clin J Pain       Date:  2022-07-01       Impact factor: 3.423

3.  Chronic Postoperative Pain After Hysterectomy for Endometrial Cancer: A Metabolic Profiling Study.

Authors:  Søren Lunde; Hien Tt Nguyen; Kristian K Petersen; Lars Arendt-Nielsen; Henrik B Krarup; Erik Søgaard-Andersen
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.